News FDA panel narrowly backs heart benefit of BI/Lilly diabetes ... FDA advisers voted 12-11 that Jardiance also reduces cardiovascular risks.
News Diabetes wearable and VR platform winners at Healthtech Summ... Insulin delivery wearable and neuro-rehabilitation virtual reality scoop top awards.
News Abbott’s needleless diabetes platform as effective as self-m... Study demonstrates a 38% reduction in time spent in hypoglycaemia, compared to traditional self monitoring.
News Victoza disappoints on cardio benefits, lifts rival Jardianc... Victoza results are significant, but fell short of investors' expectations.
News Sanofi's diabetes combo on target for showdown with Novo Rival insulin and GLP-1 combinations under review in US.
News Pharma looking to dual-action diabetes drugs to boost sales Pharma using FDA-mandated trials to give a commercial advantage.
News Roche, Viking, and Syntis showcase obesity drug candidates A flurry of clinical readouts for new weight-loss therapies has seen Roche, Viking, and Syntis all showing off new drug candidates.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
